Change template to: full
M. Alternative sources of hematopoietic stem cells (haploidentical relative donors, cord blood)
Prognostic factors in cord blood stem cell quality
Artur A. Isaev, Alexander V. Prihodko, Sergey L. Kiselev, Maria A. Lagarkova, Ivan V. Potapov, Alexey V. Lundup
Developing new immunological compatible transplants derived from umbilical cord
Artur A. Isaev1, Alexander V. Prihodko1, Irina N. Saburina2, Sergey L. Kiselev1, Varvara S. Melihova2, Ivan V. Potapov1, Alexey V. Lundup1
Ex vivo expanded hematopoietic progenitor cells (HPC) from cord blood in clinical trials for patients with hematological malignancies
Yael Margolin, David Snyder, Tony Peled
Haploidentical SCT as a salvage therapy in hematological malignancies: A single center experience
Olesya V. Paina, Yulia A. Stankevich, Ilya V. Kazantsev, Natalia V. Stancheva, Alla A. Golovacheva, Elena V. Babenko, Alexander L. Alyanskiy, Natalia E. Ivanova, Elena V. Semenova, Petr V. Krugliakov, Dmitriy G. Polyntsev, Liudmila S. Zubarovskaya, Boris V. Afanasyev
Non-T-cell depleted haploidentical HSCT after RIC in pediatric malignancies
Natalia S. Subbotina, Igor S. Dolgopolov, Roman I. Pimenov, Vasilii K. Boyarshinov, George L. Mentkevich
Properties of cord blood stem cells chromatin
Vladimir S. Tolmachev, Elizaveta I. Borovitskaya, Natalia O. Kudrina, Tatiana G. Kravtsova